Cargando…

The Use of Genetically Engineered Mouse Models for Studying the Function of Mutated Driver Genes in Pancreatic Cancer

Pancreatic cancer is often treatment-resistant, with the emerging standard of care, gemcitabine, affording only a few months of incrementally-deteriorating survival. Reflecting on the history of failed clinical trials, genetically engineered mouse models (GEMMs) in oncology research provides the ins...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weng, Ching-Chieh, Lin, Yu-Chun, Cheng, Kuang-Hung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780401/ https://www.ncbi.nlm.nih.gov/pubmed/31480737 http://dx.doi.org/10.3390/jcm8091369

Ejemplares similares

Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models
por: Saiki, Yuriko, et al.
Publicado: (2021)

Inhibition of β-Catenin Activity Abolishes LKB1 Loss-Driven Pancreatic Cystadenoma in Mice
por: Hsieh, Mei-Jen, et al.
Publicado: (2021)

Inactivation of APC Induces CD34 Upregulation to Promote Epithelial-Mesenchymal Transition and Cancer Stem Cell Traits in Pancreatic Cancer
por: Hsieh, Mei Jen, et al.
Publicado: (2020)

Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer
por: Weng, Ching-Chieh, et al.
Publicado: (2019)

SMAD4 Loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells
por: Chen, Yu-Wen, et al.
Publicado: (2014)

Functional annotation of rare gene aberration drivers of pancreatic cancer
por: Tsang, Yiu Huen, et al.
Publicado: (2016)

Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models
por: Capello, Michela, et al.
Publicado: (2013)

Anti-Tumour Efficacy of Capecitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer
por: Courtin, Aurélie, et al.
Publicado: (2013)

Deciphering The Potential Role of Hox Genes in Pancreatic Cancer
por: Kuo, Tzu-Lei, et al.
Publicado: (2019)

Identification of Five Driver Gene Mutations in Patients with Treatment-Naïve Lung Adenocarcinoma in Taiwan
por: Hsu, Kuo-Hsuan, et al.
Publicado: (2015)

Identification of driver genes based on gene mutational effects and network centrality
por: Tang, Yun-Yun, et al.
Publicado: (2021)

A CATH domain functional family based approach to identify putative cancer driver genes and driver mutations
por: Ashford, Paul, et al.
Publicado: (2019)

Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer
por: Yip-Schneider, Michele T, et al.
Publicado: (2013)

Chronic Pancreatitis and Systemic Inflammatory Response Syndrome Prevent Impact of Chemotherapy with Gemcitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer()()
por: Knoop, Richard F., et al.
Publicado: (2014)

Novel Pancreatic Cancer Cell Lines Derived from Genetically Engineered Mouse Models of Spontaneous Pancreatic Adenocarcinoma: Applications in Diagnosis and Therapy
por: Torres, María P., et al.
Publicado: (2013)

DriverRWH: discovering cancer driver genes by random walk on a gene mutation hypergraph
por: Wang, Chenye, et al.
Publicado: (2022)

Genetically Engineered Mouse Models of Pituitary Tumors
por: Cano, David A., et al.
Publicado: (2014)

Genetically engineered mouse models and human osteosarcoma
por: Ng, Alvin JM, et al.
Publicado: (2012)

Genetically Engineered Mouse Models for Liver Cancer
por: Cho, Kyungjoo, et al.
Publicado: (2019)

Mutational Profile of Driver Genes in Brazilian Melanomas
por: Vicente, Anna Luiza S.A., et al.
Publicado: (2019)

Comprehensive Characterization of Cancer Driver Genes and Mutations
por: Bailey, Matthew H., et al.
Publicado: (2018)

Genetic dissection identifies Necdin as a driver gene in a mouse model of paternal 15q duplications
por: Tamada, Kota, et al.
Publicado: (2021)

Mathematical modeling the order of driver gene mutations in colorectal cancer
por: Li, Lingling, et al.
Publicado: (2023)

The Functional Effects of Key Driver KRAS Mutations on Gene Expression in Lung Cancer
por: Zhang, Jisong, et al.
Publicado: (2020)

Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic Cancer
por: Weyandt, Jamie D., et al.
Publicado: (2015)

Preclinical Evaluation of 1,2-Diamino-4,5-Dibromobenzene in Genetically Engineered Mouse Models of Pancreatic Cancer
por: Goetze, Robert G., et al.
Publicado: (2019)

Driver Mutations of Pancreatic Cancer Affect Ca(2+) Signaling and ATP Production
por: Stopa, Kinga B, et al.
Publicado: (2023)

DriverDBv2: a database for human cancer driver gene research
por: Chung, I-Fang, et al.
Publicado: (2016)

Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers
por: Nussinov, Ruth, et al.
Publicado: (2019)

LNDriver: identifying driver genes by integrating mutation and expression data based on gene-gene interaction network
por: Wei, Pi-Jing, et al.
Publicado: (2016)

Correction: Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers
por: Nussinov, Ruth, et al.
Publicado: (2019)

Genetically engineered mouse models of human breast cancer
por: Jensen, RA
Publicado: (2003)

Genetically engineered mouse models for hereditary cancer syndromes
por: Biswas, Kajal, et al.
Publicado: (2023)

Genetically engineered mouse models of head and neck cancers
por: Tasoulas, Jason, et al.
Publicado: (2023)

Combined genetic mutations and DNA-methylated genes as biomarkers for endometrial cancer detection from cervical scrapings
por: Liew, Phui-Ly, et al.
Publicado: (2019)

Mammary pathology of the genetically engineered mouse
por: Borowsky, AD
Publicado: (2003)

Pancreatic cancer driver mutations are targetable through distant alternative RNA splicing dependencies
por: Kawalerski, Ryan R., et al.
Publicado: (2021)

Identifying overlapping mutated driver pathways by constructing gene networks in cancer
por: Wu, Hao, et al.
Publicado: (2015)

Combinatorial genetics methods for discovering high-order regulatory combinations and engineering genetic drivers for neural differentiation
por: Thean, Dawn G. L., et al.
Publicado: (2021)

Genetic mutations in SPINK1, CFTR, CTRC genes in acute pancreatitis
por: Koziel, Dorota, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_majcsak2gsfslslf526645gnqj